Calling it out? A Q Methodological Study of Sexual Harassment Labelling
Violence Against Women · 2025
DOI: 10.1177/10778012231209011 ↗Kurz gefasst
Fachartikel in der Zeitschrift Violence Against Women, 2025. Verfasst von Lisa Lazard und 2 weiteren Autor:innen. Beteiligte Einrichtung: The Open University, Milton Keynes, UK. Hauptthemen laut MEDLINE: Sexual Harassment, Crime Victims. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The public condemnation of high-profile men accused of gendered violence in 2017 resulted in an upsurge of women labelling past experiences as sexual harassment. This study used Q methodology to explore understandings of sexual harassment in the UK. Forty participants sorted 62 statements into quasi-normal grids which were factor analyzed (by person). Eight factors were identified which were titled: Sex Not Sexism, Sexualized Discriminations, Victim Voice, Sameness and Difference, Power/Sex, Repeated Power Abuse, Personal Boundaries, and Masculinity and Heterosexism. Taken together, they signal that feminist efforts to articulate the experience of sexual harassment have gained ground during this period.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Open University, Milton Keynes, UK.
ORCID-Profile: Rose Capdevila
Zitieren
APA
Lazard, L., Capdevila, R., & Turner, J. (2025). Calling it out? A Q Methodological Study of Sexual Harassment Labelling. Violence Against Women. https://doi.org/10.1177/10778012231209011
Vancouver
Lazard L, Capdevila R, Turner J. Calling it out? A Q Methodological Study of Sexual Harassment Labelling. Violence Against Women. 2025. doi:10.1177/10778012231209011
BibTeX
@article{Lazard2025,
author = {Lazard, Lisa and Capdevila, Rose and Turner, Jim},
title = {Calling it out? A Q Methodological Study of Sexual Harassment Labelling},
journal = {Violence Against Women},
year = {2025},
doi = {10.1177/10778012231209011}
}
EUVIMED